This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2vgz

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2vgz.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:2vgz.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2vgz| PDB=2vgz | SCENE= }}
{{STRUCTURE_2vgz| PDB=2vgz | SCENE= }}
-
'''CRYSTAL STRUCTURE OF HUMAN KYNURENINE AMINOTRANSFERASE II'''
+
===CRYSTAL STRUCTURE OF HUMAN KYNURENINE AMINOTRANSFERASE II===
-
==Overview==
+
<!--
-
Kynurenic acid is an endogenous neuroactive compound whose unbalancing is involved in the pathogenesis and progression of several neurological diseases. Kynurenic acid synthesis in the human brain is sustained by the catalytic activity of two kynurenine aminotransferases, hKAT I and hKAT II. A wealth of pharmacological data highlight hKAT II as a sensible target for the treatment of neuropathological conditions characterized by a kynurenic acid excess, such as schizophrenia and cognitive impairment. We have solved the structure of human KAT II by means of the single-wavelength anomalous dispersion method at 2.3-A resolution. Although closely resembling the classical aminotransferase fold, the hKAT II architecture displays unique features. Structural comparison with a prototypical aspartate aminotransferase reveals a novel antiparallel strand-loop-strand motif that forms an unprecedented intersubunit beta-sheet in the functional hKAT II dimer. Moreover, the N-terminal regions of hKAT II and aspartate aminotransferase appear to have converged to highly similar although 2-fold symmetry-related conformations, which fulfill the same functional role. A detailed structural comparison of hKAT I and hKAT II reveals a larger and more aliphatic character to the active site of hKAT II due to the absence of the aromatic cage involved in ligand binding in hKAT I. The observed structural differences could be exploited for the rational design of highly selective hKAT II inhibitors.
+
The line below this paragraph, {{ABSTRACT_PUBMED_18056996}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 18056996 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_18056996}}
==About this Structure==
==About this Structure==
Line 36: Line 40:
[[Category: Transferase]]
[[Category: Transferase]]
[[Category: Transit peptide]]
[[Category: Transit peptide]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 18:47:36 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 05:40:44 2008''

Revision as of 02:40, 28 July 2008

Image:2vgz.png

Template:STRUCTURE 2vgz

CRYSTAL STRUCTURE OF HUMAN KYNURENINE AMINOTRANSFERASE II

Template:ABSTRACT PUBMED 18056996

About this Structure

2VGZ is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Crystal Structure of Human Kynurenine Aminotransferase II, a Drug Target for the Treatment of Schizophrenia., Rossi F, Garavaglia S, Montalbano V, Walsh MA, Rizzi M, J Biol Chem. 2008 Feb 8;283(6):3559-66. Epub 2007 Dec 5. PMID:18056996

Page seeded by OCA on Mon Jul 28 05:40:44 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2vgz"
Personal tools